Analysts Set H. B. Fuller Company (NYSE:FUL) Target Price at $66.40

Shares of H. B. Fuller Company (NYSE:FUL) have earned an average rating of “Moderate Buy” from the six analysts that are presently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $67.8571.

FUL has been the subject of several analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of H. B. Fuller in a report on Tuesday. Raymond James Financial set a $67.00 price objective on shares of H. B. Fuller in a research report on Friday, June 26th. Wall Street Zen raised H. B. Fuller from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 27th. The Goldman Sachs Group set a $67.00 price objective on H. B. Fuller in a report on Friday, June 26th. Finally, Citigroup raised their target price on H. B. Fuller from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Tuesday.

H. B. Fuller Stock Up 1.2%

NYSE:FUL opened at $57.98 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.12 and a debt-to-equity ratio of 1.00. The stock has a 50 day moving average of $61.20 and a 200-day moving average of $61.28. The firm has a market capitalization of $3.12 billion, a PE ratio of 17.78, a price-to-earnings-growth ratio of 0.62 and a beta of 0.98. H. B. Fuller has a 52 week low of $48.71 and a 52 week high of $68.63.

H. B. Fuller (NYSE:FUL) last announced its quarterly earnings results on Thursday, June 25th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.04. H. B. Fuller had a return on equity of 12.18% and a net margin of 5.29%.The business had revenue of $950.27 million for the quarter, compared to the consensus estimate of $924.83 million. During the same quarter last year, the business posted $1.18 EPS. The business’s revenue was up 5.8% on a year-over-year basis. Analysts predict that H. B. Fuller will post 4.87 EPS for the current year.

H. B. Fuller Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 14th. Stockholders of record on Thursday, April 30th were paid a $0.245 dividend. The ex-dividend date of this dividend was Thursday, April 30th. This is a positive change from H. B. Fuller’s previous quarterly dividend of $0.23. This represents a $0.98 annualized dividend and a dividend yield of 1.7%. H. B. Fuller’s dividend payout ratio (DPR) is currently 30.06%.

Insider Activity at H. B. Fuller

In related news, CEO Celeste Beeks Mastin acquired 5,170 shares of the business’s stock in a transaction that occurred on Tuesday, April 7th. The shares were acquired at an average cost of $57.08 per share, for a total transaction of $295,103.60. Following the completion of the purchase, the chief executive officer directly owned 8,670 shares in the company, valued at $494,883.60. This trade represents a 147.71% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 1.83% of the company’s stock.

Hedge Funds Weigh In On H. B. Fuller

Institutional investors and hedge funds have recently bought and sold shares of the stock. Parallel Advisors LLC raised its position in shares of H. B. Fuller by 85.6% during the 1st quarter. Parallel Advisors LLC now owns 1,034 shares of the specialty chemicals company’s stock worth $64,000 after buying an additional 477 shares in the last quarter. Glenmede Trust Co. NA bought a new position in shares of H. B. Fuller in the first quarter valued at approximately $240,000. Bank of America Corp DE boosted its holdings in shares of H. B. Fuller by 36.3% in the first quarter. Bank of America Corp DE now owns 513,163 shares of the specialty chemicals company’s stock valued at $31,652,000 after acquiring an additional 136,666 shares in the last quarter. Amundi increased its stake in shares of H. B. Fuller by 23.1% during the first quarter. Amundi now owns 12,024 shares of the specialty chemicals company’s stock valued at $742,000 after acquiring an additional 2,253 shares during the period. Finally, California State Teachers Retirement System increased its stake in shares of H. B. Fuller by 19.8% during the first quarter. California State Teachers Retirement System now owns 61,623 shares of the specialty chemicals company’s stock valued at $3,801,000 after acquiring an additional 10,196 shares during the period. Institutional investors own 95.93% of the company’s stock.

About H. B. Fuller

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.